Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.
Hiromasa YamamotoJunichi SohNorihito OkumuraHiroyuki SuzukiMasao NakataToshiya FujiwaraKenichi GembaIsao SanoTakuji FujinagaMasafumi KataokaYasuhiro TerazakiNobukazu FujimotoKazuhiko KataokaShinji KosakaMotohiro YamashitaHidetoshi InokawaMasaaki InoueHiroshige NakamuraYoshinori YamashitaKatsuyuki HottaHiroshige YoshiokaSatoshi MoritaKeitaro MatsuoJunichi SakamotoHiroshi DateShinichi ToyookaPublished in: PloS one (2023)
Unique ID issued by UMIN: UMIN000007819 (Date of registration: Apr 25, 2012) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009128. Trial ID issued by jRCT: jRCTs061180089 (Date of registration: Mar 22, 2019, for a shift toward a "specified clinical trial" based on Clinical Trials Act in Japan) https://jrct.niph.go.jp/en-latest-detail/jRCTs061180089.